cell kinetic parameters; radiotherapy; DNA synthesis time; cancer; Head and neck cancer; Potential doubling time
Abstract :
[en] Purpose: The aim of this study was to assess the potential of pre-treatment cell kinetic parameters to predict outcome in head and neck cancer patients treated by conventional radiotherapy.
Materials and methods: Data from 11 different centers were pooled. Inclusion criteria were such that the patients received radiotherapy alone, and that the radiotherapy was given in an overall time of at least 6 weeks with a dose of at least 60 Gy. All patients received a tracer dose of either iododeoxyuridine (IdUrd) or bromodeoxyuridine (BrdUrd) intravenously prior to treatment and a tumor biopsy was taken several hours later. The cell kinetic parameters labeling index (LI), DNA synthesis time (Ts) and potential doubling time (Tpot) were subsequently calculated from flow cytometry data, obtained on the biopsies using antibodies against I/BrdUrd incorporated into DNA. Each center carried out their own flow cytometry analysis.
Results: From the 11 centers, a total of 476 patients conforming to the inclusion criteria were analyzed. Median values for overall time and total dose were 49 days and 69 Gy, respectively. Fifty one percent of patients had local recurrences and 53% patients had died, the majority from their disease. Median follow-up was 20 months; being 30 months for surviving patients. Multivariate analysis revealed that T-stage, maximum tumor diameter, differentiation grade, N-stage, tumor localization and overall time correlated with locoregional control, in decreasing order of significance. For the cell kinetic parameters, univariate analysis showed that only LI was significantly associated with local control (P=0.02), with higher values correlating with a worse outcome. Ts showed some evidence that patients with longer values did worse, but this was not significant (P=0.06). Tpot showed no trend (P=0.8). When assessing survival in a univariate analysis, neither LI nor Tpot associated with outcome (P=0.4, 0.4, respectively). Surprisingly, Ts did correlate with survival, with longer values being worse (P=0.02). In the multivariate analysis of local control, LI lost its significance (P=0.16).
Conclusions: The only pretreatment kinetic parameter for which some evidence was found for an association with local control (the best end-point for testing the present hypothesis) was LI, not Tpot, and this evidence disappeared in a multivariate analysis. It therefore appears that pretreatment cell kinetic measurements carried out using flow cytometry, only provide a relatively weak predictor of outcome after radiotherapy in head and neck cancer.
Amdur, R.J., Parsons, J.T., Mendenhall, W.M., Million, R.R., Cassisi, N.J., Split-course versus continuous-course irradiation in the postoperative setting for squamous cell carcinoma of the head and neck (1989) Int. J. Radiat. Oncol. Biol. Phys., 17, pp. 279-285
Antognoni, P., Bignardi, M., Cazzaniga, L.F., Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics - A phase II multicenter study (1996) Int. J. Radiat. Oncol. Biol. Phys., 36, pp. 1137-1145
Awwad, H.K., Khafagy, Y., Barsoum, M., Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: Influence of tumour proliferation (1992) Radiother. Oncol., 25, pp. 261-266
Barton, M.B., Keane, T.J., Gadalla, T., Maki, E., The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal (1992) Radiother. Oncol., 23, pp. 137-143
Begg, A.C., Hofland, I., Moonen, L., The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim report (1990) Int. J. Radiat. Oncol. Biol. Phys., 19, pp. 1449-1453
Begg, A.C., Hofland, I., Van Glabbeke, M., Horiot, J.C., Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851 (1992) Semin. Rad. Oncol., 1, pp. 22-25
Begg, A.C., McNally, N.J., Shrieve, D.C., Karcher, H., A method to measure the duration of DNA synthesis and the potential doubling time from a single sample (1985) Cytometry, 6, pp. 620-626
Begg, A.C., Moonen, L., Hofland, I., Dessing, M., Bartelink, H., Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: Intratumour sampling variations (1988) Radiother. Oncol., 11, pp. 337-347
Bennett, M.H., Wilson, G.D., Dische, S., Tumour proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous cell carcinoma in the head and neck (1992) Br. J. Cancer, 65, pp. 870-878
Bentzen, S.M., Thames, H.D., Clinical evidence for tumor clonogen regeneration: Interpretations of the data (1991) Radiother. Oncol., 22, pp. 161-166
Bourhis, J., Dendale, R., Hill, C., Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks (1996) Int. J. Radiat. Oncol. Biol. Phys., 35, pp. 471-476
Bourhis, J., Wilson, G., Wibault, P., In vivo measurement of the potential doubling time by flow cytometry in oropharyngeal cancer treated by conventional radiotherapy (1993) Int. J. Radiat. Oncol. Biol. Phys., 26, pp. 793-799
Corvo, R., Giaretti, W., Sanguineti, G., Potential doubling time in head and neck tumors treated by primary radiotherapy: Preliminary evidence for a prognostic significance in local control (1993) Int. J. Radiat. Oncol. Biol. Phys., 27, pp. 1165-1172
Corvo, R., Giaretti, W., Sanguineti, G., In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen (1995) J. Clin. Oncol., 13, pp. 1843-1850
Dean, P.N., Dolbeare, F., Gratzner, H., Rice, G.C., Gray, J.W., Cell-cycle analysis using a monoclonal antibody to BrdUrd (1984) Cell Tissue Kinet., 17, pp. 427-436
Dolbeare, F., Gratzner, H., Pallavicini, M.G., Gray, J.W., Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine (1983) Proc. Natl. Acad. Sci. USA, 80, pp. 5573-5577
Dubben, H.H., No clinical evidence for the influence of overall treatment time on TCD50 of head and neck tumours (1992) Radiother. Oncol., 25, pp. 142-143
Eschwege, F., Bourhis, J., Girinski, T., Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: A review of the Institute Gustave Roussy experience (1997) Int. J. Radiat. Oncol. Biol. Phys., 39, pp. 849-853
Fowler, J.F., Rapid repopulation in radiotherapy: A debate on mechanism. The phantom of tumor treatment-continually rapid proliferation unmasked (1991) Radiother. Oncol., 22, pp. 156-158
Fowler, J.F., Chappell, R., Local control versus dose or overall time: From coefficients to percentages (1994) Br. J. Radiol., 67, pp. 1108-1112
Fowler, J.F., Lindstrom, M.J., Loss of local control with prolongation in radiotherapy (1992) Int. J. Radiat. Oncol. Biol. Phys., 23, pp. 457-467
Fyles, A., Keane, T.J., Barton, M., Simm, J., The effect of treatment duration in the local control of cervix cancer (1992) Radiother. Oncol., 25, pp. 273-279
Gratzner, H.G., Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication (1982) Science, 21, pp. 474-475
Haustermans, K., Fowler, J., Geboes, K., Christiaens, M.R., Lerut, A., Vanderschueren, E., Relationship between potential doubling time (T-pot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure T-pot? (1998) Radiother. Oncol., 4, pp. 157-167
Haustermans, K., Hofland, I., Pottie, G., Ramaekers, M., Begg, A.C., Can measurements of potential doubling time (Tpot) be compared between laboratories? (1995) A Quality Control Study Cytometry, 19, pp. 154-163
Haustermans, K., Hofland, I., Ramaekers, M., Enrichment of tumor cells for cell kinetic analysis in human tumor biopsies using cytokeratin gating (1996) Radiother. Oncol., 41, pp. 237-248
Haustermans, K., Vanuytsel, L., Geboes, K., In vivo cell kinetic measurements in human oesophageal cancer: What can be learned from multiple biopsies? (1994) Eur. J. Cancer, 30 A, pp. 1787-1791
Horiot, J.C., Begg, A.C., Le Fur, R., Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma (1994) Recent Results Cancer Res., 134, pp. 111-119
Horiot, J.C., Bontemps, P., Vandenbogaert, W., Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial (1997) Radiother. Oncol., 44, pp. 111-121
Horiot, J.C., Leflur, R., Schraub, S., Status of the experience of the EORTC cooperative group of radiotherapy with hyperfractionated and accelerated radiotherapy (1992) Semin. Rad. Oncol., 2, pp. 34-37
Hoyer, M., Jorgensen, K., Bundgaard, T., Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck (1998) Radiother. Oncol., 46, pp. 147-155
Knee, R., Fields, R.S., Peters, L.J., Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck (1985) Radiother. Oncol., 4, pp. 1-7
Lee, W.R., Marcus R.B., Jr., Sombeck, M.D., Radiotherapy alone for carcinoma of the vagina: The importance of overall treatment time (1994) Int. J. Radiat. Oncol. Biol. Phys., 29, pp. 983-988
Lochrin, C.A., Wilson, G.D., McNally, N.J., Dische, S., Saunders, M.I., Tumor cell kinetics, local tumor control, and accelerated radiotherapy: A preliminary report (1992) Int. J. Radiat. Oncol. Biol. Phys., 24, pp. 87-91
Maciejewski, B., Skladowski, K., Pilecki, B., Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer (1996) Radiother. Oncol., 40, pp. 137-145. , Preliminary report on acute toxicity
Maciejewski, B., Skladowski, K., Tarawski, R., Zajusz, A., Is the 7-day accelerated treatment better than conventional 5-day irradiation of head and neck cancers? (1998) Progress in Radio-oncology VI, 6, p. 753. , Kogelnik HD, Sedlmayer F, editors. Bologna: Editore
Overgaard, J., Hansen, H.S., Overgaard, M., Importance of overall treatment time of radiotherapy in head and neck carcinoma (1998) Progress in Radio-oncology VI, 6, p. 743. , Experience from the Danish head and neck cancer study Kogelnik HD, Sedlmayer F, et al., editors. Bologna: Monduzzi Editore
Peters, L.J., Ang, K.K., Thames, H.D., Accelerated fractionation in the radiation treatment of head and neck cancer (1988) Acta Oncol., 2, pp. 185-194. , A critical comparison of different strategies
Rew, D.A., Campbell, I.D., Taylor, I., Wilson, G.D., Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: A flow cytometric study of 75 tumours (1992) Br. J. Surg., 7, pp. 335-339
Rew, D.A., Wilson, G.D., Taylor, I., Weaver, P.C., Proliferation characteristics of human colorectal carcinomas measured in vivo (1991) Br. J. Surg., 7, pp. 60-66
Saunders, M., Dische, S., Barrett, A., Harvey, A., Gibson, D., Parmar, M., Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomized multicentre trial (1997) Lancet, 35, pp. 161-165. , CHART Steering Committee
Steel, G.G., (1977) Growth Kinetics of Tumours, , Oxford: Oxford University Press
Struikmans, H., Rutgers, D.H., Hordijk, G.J., Slootweg, P.J., Van Der Tweel, I., Battermann, J.J., Prognostic significance of cell proliferation markers and DNA-ploidy in head and neck tumors (1998) Int. J. Radiat. Oncol. Biol. Phys., 4, pp. 27-34
Struikmans, H., Rutgers, D.H., Hordijk, G.J., Slootweg, P.J., Van Der Tweel, I., Battermann, J.J., Interrelationships of DNA-ploidy and cell proliferation markers with T-stage and N-stage in primary laryngeal tumors (1998) Int. J. Radiat. Oncol. Biol. Phys., 4, pp. 303-308
Taylor, J.M., Withers, H.R., Mendenhall, W.M., Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation (1990) Radiother. Oncol., 1, pp. 95-102
Terry, N.H., Peters, L.J., The predictive value of tumor-cell kinetic parameters in radiotherapy: Considerations regarding data production and analysis (1995) J. Clin. Oncol., 13, pp. 1833-1836
Tsang, R.W., Fyles, A.W., Kirkbride, P., Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: Correlation between two laboratories and preliminary clinical results (1995) Int. J. Radiat. Oncol. Biol. Phys., 32, pp. 1319-1329
Wilson, G.D., Assessment of human tumour proliferation using bromodeoxyuridine - Current status (1991) Acta Oncol., 3, pp. 903-910
Wilson, G.D., Dische, S., Saunders, M.I., Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy (1995) Radiother. Oncol., 36, pp. 189-197
Wilson, G.D., Paschoud, N., Pavy, J.J., Reproducibility of measurements of potential doubling time of tumour cells in the multi-centre NCI protocol T92-0045 (1999) Br. J. Cancer, 79, pp. 323-332
Wilson, M.S., West, C.M., Wilson, G.D., Roberts, S.A., James, R.D., Schofield, P.F., An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers (1993) Br. J. Cancer, 6, pp. 754-759
Wilson, M.S., West, C.M., Wilson, G.D., Roberts, S.A., James, R.D., Schofield, P.F., Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer (1993) Br. J. Cancer, 6, pp. 501-506
Withers, H.R., Taylor, J.M., Maciejewski, B., The hazard of accelerated tumor clonogen repopulation during radiotherapy (1988) Acta Oncol., 2, pp. 131-146
Zackrisson, B., Gustafsson, H., Stenling, R., Flygare, P., Wilson, G.D., Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy (1997) Int. J. Radiat. Oncol. Biol. Phys., 3, pp. 677-683
